Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
St. Jude Children's Research Hospital, Memphis, TN, USA.
Haematologica. 2021 May 1;106(5):1303-1310. doi: 10.3324/haematol.2020.246629.
Diamond Blackfan anemia (DBA) is predominantly an autosomal dominant inherited red cell aplasia primarily caused by pathogenic germline variants in ribosomal protein genes. DBA due to pathogenic RPL35A variants has been associated with large 3q29 deletions and phenotypes not common in DBA. We conducted a multi-institutional genotype-phenotype study of 45 patients with DBA associated with pathogenic RPL35A germline variants and curated the variant data on 21 additional cases from the literature. Genotype-phenotype analyses were conducted comparing patients with large deletions versus all other pathogenic variants in RPL35A. Twenty-two of the 45 cases had large deletions in RPL35A. After adjusting for multiple tests, a statistically significant association was observed between patients with a large deletion and steroid-resistant anemia, neutropenia, craniofacial abnormalities, chronic gastrointestinal problems, and intellectual disabilities (p<0.01) compared with all other pathogenic variants. Non-large deletion pathogenic variants were spread across RPL35A with no apparent hot spot and 56% of the individual family variants were observed more than once. In this, the largest known study of DBA patients with pathogenic RPL35A variants, we determined that patients with large deletions have a more severe phenotype that is clinically different from those with non-large deletion variants. Genes of interest also deleted in the 3q29 region that could be associated with some of these phenotypic features include LMLN and IQCG. Management of DBA due to large RPL35A deletions may be challenging due to complex problems and require comprehensive assessments by multiple specialists including immunologic, gastrointestinal, and developmental evaluations to provide optimal multidisciplinary care.
Diamond Blackfan 贫血(DBA)主要是一种常染色体显性遗传性红细胞再生障碍症,主要由核糖体蛋白基因的致病性种系变异引起。由致病性 RPL35A 变异引起的 DBA 与 3q29 大片段缺失和 DBA 中不常见的表型有关。我们对 45 例与致病性 RPL35A 种系变异相关的 DBA 患者进行了多机构的基因型-表型研究,并对文献中 21 例额外病例的变异数据进行了整理。通过比较大缺失与 RPL35A 中所有其他致病性变异的患者进行基因型-表型分析。在 45 例病例中,有 22 例存在 RPL35A 的大片段缺失。在进行多次检验校正后,与所有其他致病性变异相比,大缺失患者与激素抵抗性贫血、中性粒细胞减少症、颅面异常、慢性胃肠道问题和智力残疾之间存在统计学显著关联(p<0.01)。非大缺失致病性变异在 RPL35A 中分布广泛,没有明显的热点,并且观察到 56%的个体家族变异不止一次出现。在这项已知最大的致病性 RPL35A 变异 DBA 患者研究中,我们确定大缺失患者的表型更严重,与非大缺失变异患者的表型明显不同。在 3q29 区域中缺失的感兴趣基因也可能与其中一些表型特征有关,包括 LMLN 和 IQCG。由于存在复杂的问题,大 RPL35A 缺失引起的 DBA 管理可能具有挑战性,需要由多个专家(包括免疫、胃肠道和发育评估)进行全面评估,以提供最佳的多学科护理。